Literature DB >> 25613503

Fetal asphyctic preconditioning protects against perinatal asphyxia- induced apoptosis and astrogliosis in neonatal brain.

Kimberly E M Cox-Limpens1, Eveline Strackx, Daniel L A Van den Hove, Joris R A Van Ekkendonk, Marin de Jong, Luc J I Zimmermann, Harry W M Steinbusch, Johan S H Vles, Antonio W D Gavilanes.   

Abstract

Hypoxic-ischemic preconditioning is an endogenous mechanism in which exposure to a sublethal episode of hypoxia-ischemia protects against a subsequent more severe episode. Although several postnatal models of hypoxic-ischemic preconditioning have been established, hardly any perinatal models exist. Therefore, the objective of this study is to validate a new rodent model. We investigate whether mild fetal asphyxia (FA) as a preconditioning stimulus, protects against severe perinatal asphyxia (PA) when looking at neonatal brain histology. FA was induced at embryonic day 17 (E17) by temporarily clamping the uterine circulation. A caesarean section was performed at E21/22 and PA was induced by submersing the uterine horns, still containing the fetuses, in a water bath. Brains were examined for histological changes at either postnatal day 7 or 14. We used terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining to detect apoptotic cell death and a glial fibrillary acidic protein (GFAP) staining to detect reactive astrocytes. Interestingly, the preconditioned group showed significantly less perinatal mortality than non-preconditioned groups. Furthermore, preconditioned animals had significantly less TUNEL-positive cells and less GFAP-positive cells in striatum, prefrontal cortex and hippocampus compared to the non-preconditioned animals that underwent PA. Consequently, mild FA might cause neuroprotection by inducing anti-apoptotic mechanisms and attenuating astrogliosis. Considering the morphological findings in the neonatal brain from this study, together with previously reported long-term behavioral outcomes in this model, we can conclude that this is a suitable experimental model to investigate mechanisms of endogenous neuroprotection in the fetal brain. Identifying these endogenous neuroprotective mechanisms will provide novel potential targets for future pharmacological intervention in asphyctic newborns.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25613503     DOI: 10.2174/1871527314666150116112032

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  3 in total

1.  Kolaviron was protective against sodium azide (NaN3) induced oxidative stress in the prefrontal cortex.

Authors:  Olayemi J Olajide; Bernard U Enaibe; Oluwamolakun O Bankole; Oluwole B Akinola; Babafemi J Laoye; Olalekan M Ogundele
Journal:  Metab Brain Dis       Date:  2015-04-29       Impact factor: 3.584

2.  Brain caspase-3 and intestinal FABP responses in preterm and term rats submitted to birth asphyxia.

Authors:  R L Figueira; F L Gonçalves; A L Simões; C A Bernardino; L S Lopes; O Castro E Silva; L Sbragia
Journal:  Braz J Med Biol Res       Date:  2016-06-23       Impact factor: 2.590

3.  Pretreatment with Group II Metabotropic Glutamate Receptor Agonist LY379268 Protects Neonatal Rat Brains from Oxidative Stress in an Experimental Model of Birth Asphyxia.

Authors:  Ewelina Bratek; Apolonia Ziembowicz; Elzbieta Salinska
Journal:  Brain Sci       Date:  2018-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.